QLGN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Qualigen Therapeutics Inc

NASDAQ | QLGN

3.04

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 17, 2025)

$5.55M

Market Cap

0.432

P/E Ratio

6.32

EPS

$6.48

52 Week High

$1.61

52 Week Low

HEALTHCARE

Sector

QLGN Chart

Recent Chart
Price Action

QLGN Technicals

Tags:

QLGN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$5.8M
Selling General And Administrative $4.2M
Research And Development $1.2M
Operating Expenses $5.8M
Investment Income Net -
Net Interest Income -$780K
Interest Income $129K
Interest Expense $909K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$6.2M
Income Tax Expense $6.3K
Interest And Debt Expense -
Net Income From Continuing Operations -$6.2M
Comprehensive Income Net Of Tax -
Ebit -$5.8M
Ebitda -$5.2M
Net Income -$6.2M

Revenue & Profitability

Earnings Performance

QLGN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $4.7M
Total Current Assets $4.7M
Cash And Cash Equivalents At Carrying Value $1.2M
Cash And Short Term Investments $1.2M
Inventory -
Current Net Receivables $2M
Total Non Current Assets $2K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.5M
Other Non Current Assets -
Total Liabilities $2M
Total Current Liabilities $2M
Current Accounts Payable $1.6M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $439K
Other Non Current Liabilities -
Total Shareholder Equity $2.7M
Treasury Stock -
Retained Earnings -$123M
Common Stock $65K
Common Stock Shares Outstanding $362K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$6.3M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $0
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.9M
Cashflow From Financing $9M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $88K
Dividend Payout Common Stock $88K
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$6.4M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$5.8M
Selling General And Administrative $4.2M
Research And Development $1.2M
Operating Expenses $5.8M
Investment Income Net -
Net Interest Income -$780K
Interest Income $129K
Interest Expense $909K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$6.2M
Income Tax Expense $6.3K
Interest And Debt Expense -
Net Income From Continuing Operations -$6.2M
Comprehensive Income Net Of Tax -
Ebit -$5.8M
Ebitda -$5.2M
Net Income -$6.2M

QLGN News

QLGN Profile

Qualigen Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Qualigen Therapeutics Inc. is a biotechnology company headquartered in Carlsbad, California, dedicated to developing innovative therapeutic solutions for cancer and infectious diseases. Utilizing advanced science and technology, Qualigen is focused on addressing significant unmet medical needs through its product pipeline, which includes both targeted therapies and diagnostic tools. With a commitment to improving patient outcomes and enhancing the quality of life, the company is strategically positioned as a key player in the biopharmaceutical sector, aiming to make meaningful contributions to global healthcare advancements.

WTO
+25.52%
$0.03
LPTX
+368.57%
$2.05
APLT
+30.18%
$0.28
VINE
+1.80%
$0.40
AMIX
+58.18%
$1.15
VHAI
+33.33%
$0.00
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
IVVD
+32.76%
$2.35
CHR
-2.87%
$0.04
ASST
-3.70%
$1.04
TSLA
+1.13%
$408.92
GLMD
+4.80%
$1.09
SOFI
-2.80%
$27.04
F
-2.38%
$12.87
PLUG
-7.12%
$2.08
INTC
-2.28%
$34.71
QUBT
+8.49%
$11.50
PFE
0.00%
$25.05
DVLT
+4.09%
$1.90
GNS
-11.60%
$0.76
AXDX
-61.36%
$0.03
PLTR
+1.08%
$174.01
BYND
-3.70%
$1.04
DNN
-4.03%
$2.38
RIVN
-7.80%
$15.11
AMZN
-0.77%
$232.87
BITF
+3.48%
$2.67
ACHR
-5.78%
$7.42
ETHD
+8.89%
$5.69
DFLI
-1.27%
$0.80
KVUE
-2.61%
$16.22
MARA
-4.00%
$11.51
NIO
-1.46%
$6.07
GOOGL
+3.11%
$285.02
ADAP
-15.14%
$0.05
BMNR
-5.93%
$34.40
SNAP
-4.49%
$8.18
IREN
-4.68%
$46.37
RIG
+1.62%
$4.07
BURU
-13.30%
$0.21
TLRY
-4.93%
$1.02
CIFR
-0.06%
$14.35
AAPL
-1.81%
$267.46
RGTI
-3.10%
$24.69
AAL
-3.29%
$12.34
GRAB
-1.47%
$5.33
WULF
+0.54%
$11.05
ASBP
-14.11%
$0.09
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
MSPR
+18.40%
$0.53
HPE
-7.74%
$21.06
AMD
-2.54%
$240.52
BAC
-2.11%
$51.49
BTG
-2.56%
$3.99
XPEV
-10.33%
$22.42
CAN
-4.37%
$0.85
SRM
+53.27%
$10.30
T
-0.54%
$25.45
NOK
-0.89%
$6.67
HOOD
+0.79%
$122.50
NBIS
-5.74%
$83.54
GPUS
-7.60%
$0.27
PLTD
-1.01%
$6.84
MU
-1.97%
$241.95
QBTS
-3.26%
$22.84
GOOG
+3.15%
$285.73
OWL
-5.77%
$13.77
HIMS
-3.78%
$35.58
HBAN
-2.73%
$15.30
IONQ
+3.92%
$47.18
CSCO
-0.28%
$77.78
WLGS
-5.57%
$0.04
SOUN
-0.40%
$12.17
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
XPON
-8.66%
$1.16
IONZ
-1.30%
$5.13
SMCI
-6.42%
$34.08
BTBT
-3.32%
$2.32
BBD
-1.76%
$3.61
WBD
-1.77%
$22.62
BTE
+0.63%
$3.16
CRWV
-2.62%
$75.33
DEFT
-15.17%
$1.23
ABEV
-0.39%
$2.54
APLD
-3.02%
$22.93
EOSE
-5.79%
$13.00
RXRX
-0.48%
$4.12
SMR
-6.23%
$21.05
CLF
+2.28%
$10.97
TWOH
0.00%
$0.00
QS
-3.42%
$12.97
AFMD
-34.94%
$0.18
PSNY
-16.34%
$0.52
CLSK
-3.42%
$10.58
AMCR
-0.29%
$8.45
JOBY
-3.60%
$13.89
WTO
+25.52%
$0.03
LPTX
+368.57%
$2.05
APLT
+30.18%
$0.28
VINE
+1.80%
$0.40
AMIX
+58.18%
$1.15
VHAI
+33.33%
$0.00
NVDA
-1.87%
$186.60
ONDS
-12.88%
$6.25
IVVD
+32.76%
$2.35
CHR
-2.87%
$0.04
ASST
-3.70%
$1.04
TSLA
+1.13%
$408.92
GLMD
+4.80%
$1.09
SOFI
-2.80%
$27.04
F
-2.38%
$12.87
PLUG
-7.12%
$2.08
INTC
-2.28%
$34.71
QUBT
+8.49%
$11.50
PFE
0.00%
$25.05
DVLT
+4.09%
$1.90
GNS
-11.60%
$0.76
AXDX
-61.36%
$0.03
PLTR
+1.08%
$174.01
BYND
-3.70%
$1.04
DNN
-4.03%
$2.38
RIVN
-7.80%
$15.11
AMZN
-0.77%
$232.87
BITF
+3.48%
$2.67
ACHR
-5.78%
$7.42
ETHD
+8.89%
$5.69
DFLI
-1.27%
$0.80
KVUE
-2.61%
$16.22
MARA
-4.00%
$11.51
NIO
-1.46%
$6.07
GOOGL
+3.11%
$285.02
ADAP
-15.14%
$0.05
BMNR
-5.93%
$34.40
SNAP
-4.49%
$8.18
IREN
-4.68%
$46.37
RIG
+1.62%
$4.07
BURU
-13.30%
$0.21
TLRY
-4.93%
$1.02
CIFR
-0.06%
$14.35
AAPL
-1.81%
$267.46
RGTI
-3.10%
$24.69
AAL
-3.29%
$12.34
GRAB
-1.47%
$5.33
WULF
+0.54%
$11.05
ASBP
-14.11%
$0.09
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
MSPR
+18.40%
$0.53
HPE
-7.74%
$21.06
AMD
-2.54%
$240.52
BAC
-2.11%
$51.49
BTG
-2.56%
$3.99
XPEV
-10.33%
$22.42
CAN
-4.37%
$0.85
SRM
+53.27%
$10.30
T
-0.54%
$25.45
NOK
-0.89%
$6.67
HOOD
+0.79%
$122.50
NBIS
-5.74%
$83.54
GPUS
-7.60%
$0.27
PLTD
-1.01%
$6.84
MU
-1.97%
$241.95
QBTS
-3.26%
$22.84
GOOG
+3.15%
$285.73
OWL
-5.77%
$13.77
HIMS
-3.78%
$35.58
HBAN
-2.73%
$15.30
IONQ
+3.92%
$47.18
CSCO
-0.28%
$77.78
WLGS
-5.57%
$0.04
SOUN
-0.40%
$12.17
VALE
-1.05%
$12.17
MTSR
-0.35%
$70.50
XPON
-8.66%
$1.16
IONZ
-1.30%
$5.13
SMCI
-6.42%
$34.08
BTBT
-3.32%
$2.32
BBD
-1.76%
$3.61
WBD
-1.77%
$22.62
BTE
+0.63%
$3.16
CRWV
-2.62%
$75.33
DEFT
-15.17%
$1.23
ABEV
-0.39%
$2.54
APLD
-3.02%
$22.93
EOSE
-5.79%
$13.00
RXRX
-0.48%
$4.12
SMR
-6.23%
$21.05
CLF
+2.28%
$10.97
TWOH
0.00%
$0.00
QS
-3.42%
$12.97
AFMD
-34.94%
$0.18
PSNY
-16.34%
$0.52
CLSK
-3.42%
$10.58
AMCR
-0.29%
$8.45
JOBY
-3.60%
$13.89
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.